273 related articles for article (PubMed ID: 17786466)
1. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis.
Hu J; Hoang QV; Chau FY; Blair MP; Lim JI
Retin Cases Brief Rep; 2014; 8(1):24-9. PubMed ID: 25372202
[TBL] [Abstract][Full Text] [Related]
4. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
Ahmadieh H; Vafi N
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.
Schadlu R; Blinder KJ; Shah GK; Holekamp NM; Thomas MA; Grand MG; Engelbrecht NE; Apte RS; Joseph DP; Prasad AG; Smith BT; Sheybani A
Am J Ophthalmol; 2008 May; 145(5):875-8. PubMed ID: 18321466
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
[TBL] [Abstract][Full Text] [Related]
7. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
9. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab during pregnancy.
Tarantola RM; Folk JC; Boldt HC; Mahajan VB
Retina; 2010 Oct; 30(9):1405-11. PubMed ID: 20924262
[TBL] [Abstract][Full Text] [Related]
11. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis.
Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM
Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795
[TBL] [Abstract][Full Text] [Related]
12. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.
Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A
Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome.
Nielsen JS; Fick TA; Saggau DD; Barnes CH
Retina; 2012 Mar; 32(3):468-72. PubMed ID: 21817958
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
15. [Neovascular membrane and pregnancy. Treatment with bevacizumab].
Gómez Ledesma I; de Santiago Rodríguez MÁ; Follana Neira I; León Garrigosa F
Arch Soc Esp Oftalmol; 2012 Sep; 87(9):297-300. PubMed ID: 22824650
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
Chan WM; Lai TY; Liu DT; Lam DS
Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
Makragiannis G; Vahdani K; Carreño E; Lee RWJ; Dick AD; Ross AH
Int Ophthalmol; 2018 Apr; 38(2):781-785. PubMed ID: 28361379
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
Narayanan R; Shah VA
Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.
Theodossiadis PG; Grigoropoulos VG; Emfietzoglou I; Vergados J; Chalkiadakis J; Theodossiadis GP
Eur J Ophthalmol; 2007; 17(5):853-6. PubMed ID: 17932868
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
Sachdev N; Vishwanathan K; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2007; 55(6):457-8. PubMed ID: 17951904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
